Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-03-02 00:08 |
FORM 6- Annual General Meeting of Shareholders will be held on Tuesday, April …
|
English | 524.3 KB | ||
| 2025-03-02 00:08 |
FORM 6- Annual General Meeting of Shareholders will be held on Tuesday, April …
|
English | 36.9 KB | ||
| 2025-02-18 15:11 |
6K: Purple Biotech Advances NT219 into Phase 2 Head and Neck Cancer Trial
|
English | 180.6 KB | ||
| 2025-02-18 15:11 |
6K: Purple Biotech Advances NT219 into Phase 2 Head and Neck Cancer Trial
|
English | 36.6 KB | ||
| 2025-02-03 15:14 |
Research Collaboration with the Icahn School of Medicine at Mount Sinai for CAP…
|
English | 192.0 KB | ||
| 2025-02-03 15:14 |
Research Collaboration with the Icahn School of Medicine at Mount Sinai for CAP…
|
English | 36.7 KB | ||
| 2025-01-07 09:23 |
6K- ATM
|
English | 147.7 KB | ||
| 2025-01-07 09:23 |
6K- ATM
|
English | 36.5 KB | ||
| 2025-01-07 01:03 |
PROSPECTUS SUPPLEMENT (to Prospectus Supplement dated October 17, 2023, to Pros…
|
English | 130.2 KB | ||
| 2025-01-07 01:03 |
PROSPECTUS SUPPLEMENT (to Prospectus Supplement dated October 17, 2023, to Pros…
|
English | 35.9 KB | ||
| 2024-12-07 21:47 |
Purple Biotech Corporate Presentation December 2024
|
English | 7.1 MB | ||
| 2024-12-07 21:47 |
Purple Biotech Corporate Presentation December 2024
|
English | 36.6 KB | ||
| 2024-12-05 15:31 |
Closing of $2.8 Million Registered Direct Offering of American Depositary Share…
|
English | 165.4 KB | ||
| 2024-12-05 15:31 |
Closing of $2.8 Million Registered Direct Offering of American Depositary Share…
|
English | 36.7 KB | ||
| 2024-12-04 21:14 |
6K: Transaction documents
|
English | 493.5 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
